(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1322944 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CLK1 mRNA CTD PMID:22079256 1,2-dimethylhydrazine decreases expression ISO RGD:1550637 6480464 1, 2-Dimethylhydrazine results in decreased expression of CLK1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1550637 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLK1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1550637 6480464 Ethinyl Estradiol affects the expression of CLK1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CLK1 mRNA CTD PMID:17557909 17alpha-ethynylestradiol decreases expression ISO RGD:1550637 6480464 Ethinyl Estradiol results in decreased expression of CLK1 mRNA CTD PMID:17942748 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CLK1 mRNA CTD PMID:32145629 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CLK1 mRNA CTD PMID:35192832 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CLK1 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CLK1 mRNA CTD PMID:32109520 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550637 6480464 Tetrachlorodibenzodioxin affects the expression of CLK1 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-D decreases expression ISO RGD:1322944 6480464 2, 4-Dichlorophenoxyacetic Acid results in decreased expression of CLK1 mRNA CTD PMID:15878651 2-hydroxypropanoic acid affects expression ISO RGD:1322944 6480464 Lactic Acid affects the expression of CLK1 mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1322944 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CLK1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1322944 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CLK1 mRNA CTD PMID:28628672 5-iodotubercidin decreases activity ISO RGD:1322944 6480464 5-iodotubercidin results in decreased activity of CLK1 protein CTD PMID:26953159 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CLK1 mRNA CTD PMID:30047161 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CLK1 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1322944 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CLK1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CLK1 mRNA CTD PMID:32699268 acrylamide increases expression ISO RGD:1550637 6480464 Acrylamide results in increased expression of CLK1 mRNA CTD PMID:35032568 acrylamide increases expression ISO RGD:1322944 6480464 Acrylamide results in increased expression of CLK1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:1550637 6480464 Aflatoxin B1 results in increased expression of CLK1 mRNA CTD PMID:19770486 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CLK1 mRNA CTD PMID:22484513 alpha-pinene multiple interactions ISO RGD:1322944 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CLK1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CLK1 mRNA CTD PMID:32699268 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of CLK1 mRNA CTD PMID:30047161 Aroclor 1254 decreases expression ISO RGD:1550637 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CLK1 mRNA CTD PMID:23650126 arsenous acid increases expression ISO RGD:1322944 6480464 Arsenic Trioxide results in increased expression of CLK1 mRNA CTD PMID:20458559 benzo[a]pyrene increases expression ISO RGD:1550637 6480464 Benzo(a)pyrene results in increased expression of CLK1 mRNA CTD PMID:20127859 , PMID:22228805 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CLK1 mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CLK1 mRNA CTD PMID:34947998 , PMID:35192832 bisphenol A decreases expression ISO RGD:1550637 6480464 bisphenol A results in decreased expression of CLK1 mRNA CTD PMID:33221593 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CLK1 mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:1550637 6480464 bisphenol A results in increased expression of CLK1 mRNA CTD PMID:25594700 cadmium atom increases expression ISO RGD:1322944 6480464 Cadmium results in increased expression of CLK1 mRNA CTD PMID:21120746 , PMID:24284285 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CLK1 mRNA CTD PMID:19010381 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of CLK1 mRNA CTD PMID:20349343 carbon nanotube decreases expression ISO RGD:1550637 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1550637 6480464 Nanotubes, Carbon results in increased expression of CLK1 mRNA CTD PMID:25620056 carbonyl sulfide decreases expression EXP 6480464 carbonyl sulfide results in decreased expression of CLK1 mRNA CTD PMID:19395590 chloropicrin increases expression ISO RGD:1322944 6480464 chloropicrin results in increased expression of CLK1 mRNA CTD PMID:26352163 cisplatin increases expression ISO RGD:1322944 6480464 Cisplatin results in increased expression of CLK1 mRNA CTD PMID:33545341 cisplatin multiple interactions ISO RGD:1322944 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CLK1 mRNA CTD PMID:27392435 cobalt dichloride increases expression ISO RGD:1322944 6480464 cobaltous chloride results in increased expression of CLK1 mRNA CTD PMID:19320972 , PMID:19376846 cocaine increases expression ISO RGD:1550637 6480464 Cocaine results in increased expression of CLK1 mRNA CTD PMID:18355967 cocaine multiple interactions ISO RGD:1550637 6480464 FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of CLK1 mRNA] CTD PMID:18355967 copper atom increases expression EXP 6480464 Copper results in increased expression of CLK1 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of CLK1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1322944 6480464 Copper Sulfate results in increased expression of CLK1 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:1322944 6480464 coumarin results in increased phosphorylation of CLK1 protein CTD PMID:35688186 crocidolite asbestos increases expression ISO RGD:1322944 6480464 Asbestos, Crocidolite results in increased expression of CLK1 mRNA CTD PMID:18687144 crotonaldehyde increases expression ISO RGD:1322944 6480464 2-butenal results in increased expression of CLK1 mRNA CTD PMID:20471460 CU-O LINKAGE increases expression ISO RGD:1322944 6480464 cupric oxide results in increased expression of CLK1 mRNA CTD PMID:22077320 cyclosporin A increases expression ISO RGD:1322944 6480464 Cyclosporine results in increased expression of CLK1 mRNA CTD PMID:20106945 more ... deguelin increases expression ISO RGD:1322944 6480464 deguelin results in increased expression of CLK1 mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO RGD:1322944 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CLK1 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1322944 6480464 Arsenic Trioxide results in increased expression of CLK1 mRNA CTD PMID:20458559 dicrotophos decreases expression ISO RGD:1322944 6480464 dicrotophos results in decreased expression of CLK1 mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of CLK1 mRNA CTD PMID:22546817 diethyl maleate increases expression ISO RGD:1322944 6480464 diethyl maleate results in increased expression of CLK1 mRNA CTD PMID:33545341 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CLK1 mRNA CTD PMID:21658437 doxorubicin increases expression ISO RGD:1322944 6480464 Doxorubicin results in increased expression of CLK1 mRNA CTD PMID:29803840 elesclomol multiple interactions ISO RGD:1322944 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of CLK1 mRNA] CTD PMID:18723479 elesclomol increases expression ISO RGD:1322944 6480464 elesclomol results in increased expression of CLK1 mRNA CTD PMID:18723479 epoxiconazole increases expression ISO RGD:1550637 6480464 epoxiconazole results in increased expression of CLK1 mRNA CTD PMID:35436446 fluoranthene multiple interactions ISO RGD:1550637 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of CLK1 mRNA CTD PMID:28329830 flusilazole affects expression ISO RGD:1550637 6480464 flusilazole affects the expression of CLK1 mRNA CTD PMID:21195148 folic acid multiple interactions ISO RGD:1550637 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLK1 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:1322944 6480464 Formaldehyde results in increased expression of CLK1 mRNA CTD PMID:20655997 fulvestrant increases expression ISO RGD:1322944 6480464 fulvestrant results in increased expression of CLK1 mRNA CTD PMID:12154049 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CLK1 mRNA CTD PMID:22061828 , PMID:33387578 hexaconazole affects expression ISO RGD:1550637 6480464 hexaconazole affects the expression of CLK1 mRNA CTD PMID:21195148 indirubin decreases expression ISO RGD:1322944 6480464 indirubin results in decreased expression of CLK1 mRNA CTD PMID:15056799 indometacin multiple interactions ISO RGD:1322944 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CLK1 mRNA CTD PMID:28628672 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of CLK1 mRNA CTD PMID:20080153 leflunomide increases expression ISO RGD:1322944 6480464 leflunomide results in increased expression of CLK1 mRNA CTD PMID:28988120 mercury atom affects expression ISO RGD:1322944 6480464 Mercury affects the expression of CLK1 mRNA CTD PMID:16823088 mercury(0) affects expression ISO RGD:1322944 6480464 Mercury affects the expression of CLK1 mRNA CTD PMID:16823088 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CLK1 mRNA CTD PMID:22484513 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of CLK1 mRNA CTD PMID:30047161 methylisothiazolinone increases expression ISO RGD:1322944 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of CLK1 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1322944 6480464 methylmercuric chloride results in increased expression of CLK1 mRNA CTD PMID:28001369 miconazole decreases expression ISO RGD:1550637 6480464 Miconazole results in decreased expression of CLK1 mRNA CTD PMID:27462272 mono(2-ethyl-5-oxohexyl) phthalate affects expression ISO RGD:1322944 6480464 mono(2-ethyl-5-oxohexyl)phthalate affects the expression of CLK1 mRNA CTD PMID:34478338 N-acetyl-L-cysteine multiple interactions ISO RGD:1322944 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of CLK1 mRNA] CTD PMID:18723479 N-acetylsphingosine increases expression ISO RGD:1550637 6480464 N-acetylsphingosine results in increased expression of CLK1 mRNA CTD PMID:18270325 nickel dichloride increases expression ISO RGD:1322944 6480464 nickel chloride results in increased expression of CLK1 mRNA CTD PMID:17312168 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CLK1 mRNA CTD PMID:22546817 ozone multiple interactions ISO RGD:1322944 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CLK1 mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:1550637 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CLK1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CLK1 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1550637 6480464 Acetaminophen results in increased expression of CLK1 mRNA CTD PMID:11264010 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CLK1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1322944 6480464 Acetaminophen results in increased expression of CLK1 mRNA CTD PMID:21420995 paracetamol affects expression ISO RGD:1550637 6480464 Acetaminophen affects the expression of CLK1 mRNA CTD PMID:15606129 paraoxon increases expression ISO RGD:1550637 6480464 Paraoxon results in increased expression of CLK1 mRNA CTD PMID:22093924 patulin decreases expression ISO RGD:1322944 6480464 Patulin results in decreased expression of CLK1 mRNA CTD PMID:27913847 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1322944 6480464 perfluorooctane sulfonic acid results in decreased expression of CLK1 mRNA CTD PMID:27153767 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1550637 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CLK1 mRNA CTD PMID:36331819 phenobarbital affects expression ISO RGD:1322944 6480464 Phenobarbital affects the expression of CLK1 mRNA CTD PMID:19159669 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CLK1 mRNA CTD PMID:22484513 potassium chromate multiple interactions ISO RGD:1322944 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CLK1 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1322944 6480464 potassium chromate(VI) results in increased expression of CLK1 mRNA CTD PMID:22079256 potassium nitrate decreases expression ISO RGD:1322944 6480464 potassium nitrate results in decreased expression of CLK1 mRNA CTD PMID:15878651 quercetin increases expression ISO RGD:1322944 6480464 Quercetin results in increased expression of CLK1 mRNA CTD PMID:21632981 rac-lactic acid affects expression ISO RGD:1322944 6480464 Lactic Acid affects the expression of CLK1 mRNA CTD PMID:30851411 raloxifene increases expression ISO RGD:1322944 6480464 Raloxifene Hydrochloride results in increased expression of CLK1 mRNA CTD PMID:12154049 rotenone increases expression ISO RGD:1322944 6480464 Rotenone results in increased expression of CLK1 mRNA CTD PMID:33512557 silicon dioxide increases expression ISO RGD:1322944 6480464 Silicon Dioxide analog results in increased expression of CLK1 mRNA CTD PMID:25895662 silver atom increases expression ISO RGD:1322944 6480464 Silver results in increased expression of CLK1 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1322944 6480464 Silver results in increased expression of CLK1 mRNA CTD PMID:26014281 sodium arsenite increases expression ISO RGD:1322944 6480464 sodium arsenite results in increased expression of CLK1 mRNA CTD PMID:12016162 , PMID:12760830 sodium arsenite decreases expression ISO RGD:1322944 6480464 sodium arsenite results in decreased expression of CLK1 mRNA CTD PMID:28595984 , PMID:34032870 succimer multiple interactions ISO RGD:1550637 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLK1 mRNA CTD PMID:21641980 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of CLK1 mRNA CTD PMID:30047161 sunitinib increases expression ISO RGD:1322944 6480464 Sunitinib results in increased expression of CLK1 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1550637 6480464 Tamoxifen affects the expression of CLK1 mRNA CTD PMID:17555576 , PMID:20937368 tetrachloromethane increases methylation EXP 6480464 Carbon Tetrachloride results in increased methylation of CLK1 promoter CTD PMID:30690589 tetrachloromethane increases expression ISO RGD:1550637 6480464 Carbon Tetrachloride results in increased expression of CLK1 mRNA CTD PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CLK1 mRNA CTD PMID:30690589 tetraphene affects expression ISO RGD:1550637 6480464 benz(a)anthracene affects the expression of CLK1 mRNA CTD PMID:26377693 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CLK1 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1550637 6480464 titanium dioxide results in decreased expression of CLK1 mRNA CTD PMID:23557971 triadimefon affects expression ISO RGD:1550637 6480464 triadimefon affects the expression of CLK1 mRNA CTD PMID:21195148 triptonide increases expression ISO RGD:1550637 6480464 triptonide results in increased expression of CLK1 mRNA CTD PMID:33045310 trovafloxacin increases expression ISO RGD:1550637 6480464 trovafloxacin results in increased expression of CLK1 mRNA CTD PMID:35537566 tungsten increases expression ISO RGD:1550637 6480464 Tungsten results in increased expression of CLK1 mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:1550637 6480464 Valproic Acid affects the expression of CLK1 mRNA CTD PMID:17963808 valproic acid decreases expression ISO RGD:1322944 6480464 Valproic Acid results in decreased expression of CLK1 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1550637 6480464 Valproic Acid results in decreased expression of CLK1 mRNA CTD PMID:20546886 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CLK1 mRNA CTD PMID:23555832 zinc atom multiple interactions ISO RGD:1322944 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CLK1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1322944 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of CLK1 mRNA CTD PMID:18593933
